The global epileptic seizures treatment market is expected to grow at a moderate CAGR of ~4% during the forecast period.
The global epileptic seizures treatment market is expected to grow at a moderate CAGR of ~4% during the forecast period.
Development of New Vaccines and Drugs to Increase Adoption of Existing Epileptic Seizures Treatment
Epilepsy is categorized as a chronic disease of the brain and continues to affect millions of individuals worldwide. Although the prevalence of epilepsy is marginally higher in men compared to women, it affects individuals from all age groups. The prevalence of focal seizures is higher than that of generalized seizures in both, children as well as adults. The prevalence of epileptic seizures is higher in low to middle-income countries due to which, the demand for epileptic seizure treatment is high from developing regions. Some of the major factors responsible for the high prevalence of epileptic seizures in developing regions include acute symptomatic seizures, misdiagnosis, and lack of advanced medical infrastructure.
Download Sample @ https://qyresearchmedical.com/sample/111591
As epilepsy continues to emerge as a critical cause of mortality and disability around the world, considerable attention has been given to the development and discovery of new epileptic seizures treatment– a factor that is expected to drive the epileptic seizures treatment market during the forecast period. At present, players involved in the current epileptic seizures treatment market are increasingly focusing on reducing the burden of epileptic seizures, improving the access to the existing epileptic seizures treatments, and development of new vaccines and drugs particularly in the low/middle-income countries.
At the back of these factors, along with considerable rise in the number of research and development activities, the global epileptic seizures treatment market is on course to surpass the US$ 1.8 Bn mark by the end of 2030.
Increasing Focus on Providing Seizure-free Life to Fuel Innovations
Over the past few decades, apart from conventional strategies deployed to treat epileptic seizures, including medicine and surgery, a number of alternative treatment options such as deep brain stimulation, vague nerve stimulation, and adoption of ketogenic diet have emerged. As the focus on providing a seizure-free life continues to remain high, considerable improvements have been made in epilepsy diagnosis and treatment. For instance, a range of wearable seizure detectors have been developed that play a key role in tracking the seizure activities of individuals. These devices are likely to minimize unexpected deaths caused by uncontrolled seizures and thereby, increase the demand for epileptic seizures treatment.
Due to the increasing demand for minimally invasive surgeries, a number of new treatment alternatives have gained considerable momentum in recent years. For instance, stereotactic radiosurgery has gradually gained considerable spotlight as a feasible, effective, and an ideal minimally invasive epileptic seizures treatment– a factor that will continue to drive the growth of the global epileptic seizures treatment market in the upcoming years. Furthermore, MRI-guided laser ablation is another treatment alternative that is expected to gain noteworthy adoption in the upcoming years and provide a considerable boost to the growth of the market for epileptic seizures treatment.
While advancements at the surgical front are expected to remain steady throughout the forecast period, considerable progress has been made in the drug-based treatment sphere. A number of researchers and medical experts is increasingly collaborating with each other to improve the current state of epileptic seizures treatment– a factor that is likely to boost market growth.
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/111591/2900
Adoption of Telemedicine Services to Grow amid COVID-19 Pandemic
The advent of the novel COVID-19 pandemic is projected to have a low impact on the overall growth of the global epileptic seizures treatment market in 2020. Research and development activities in the epileptic seizures treatment market continue to explore the potential risk of contracting the COVID-19 infection among epileptic patients. Some research findings suggest that epileptic patients are at a higher risk of contracting the novel coronavirus disease due to which, the demand for telemedicine services continues to grow within the epileptic seizures treatment market. The increasing demand for telemedicine epileptic seizures treatment during the ongoing pandemic is projected to provide a considerable boost to the growth of the global epileptic seizures treatment market in 2020.
Analysts’ Viewpoint
The global epileptic seizures treatment market is expected to grow at a moderate CAGR of ~4% during the forecast period. Increasing prevalence of epileptic seizures in patients worldwide, focus on providing a seizure-free life to patients, entry of a number of seizure detection devices, advancements in technology, and focus on research and development. Market players should focus on improving the efficacy of existing treatments and improving the accessibility to current epileptic seizures treatments particularly in developing regions.
Epileptic Seizures Treatment Market: Overview
Seizures, which are abnormal movements or behavior due to unusual electrical activity in the brain, are symptoms of epilepsy
Epilepsy is a chronic brain disease, which is non-communicable, affecting people of all ages. It causes recurring seizures, which are short episodes of involuntary movement.
Several drugs are used for treatment of epileptic seizures; however benzodiazepine class is the most common, which is highly used for the control of seizures
Benzodiazepine drugs are more effective therapy for epileptic seizures. These have been developed with less possible side effects and novel route of administration in the past few years.
Phenytoin, fosphenytoin, and other ant-epileptic drugs are also used for the treatment of epileptic seizures
Epileptic Seizures Treatment Market: Drivers
Rise in prevalence of status epilepticus and acute repetitive seizures is the major factor boosting the growth of the global epileptic seizures treatment market
Introduction of novel drug treatments and route of administration for epileptic seizures fuels the growth of the global epileptic seizures treatment market
For instance, in January 2020, the U.S. FDA approved Neurilis, Inc.’s Valtoco (diazepam nasal spray) in the U.S. This is a new seizure medicine designed to treat periods of frequent seizures or cluster seizures.
Moreover, genetic factors associated with brain malformations & epileptic seizures, and increase in incidence of cardiovascular diseases, head injuries, brain cancer, infections, and substance abuse are the other factors accelerating the growth of the global epileptic seizures treatment market
Market Segmentation: Epileptic Seizures Treatment Market
In terms of therapeutic, the global epileptic seizures treatment market has been classified into midazolam, alprazolam, diazepam, lorazepam, phenytoin, fosphenytoin, and others
Based on type, the global epileptic seizures treatment market has been divided into repetitive seizures, status epilepticus, and others. The status epilepticus segment has been bifurcated into convulsive status epilepticus and non-convulsive status epilepticus.
In terms of route of administration, the global epileptic seizures treatment market has been categorized into oral/buccal, rectal, nasal, and parenteral
Based on distribution channel, the global epileptic seizures treatment market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies
Each of the epileptic seizures treatment market segments has been analyzed in detail for market trends, recent trends and developments, drivers, restraints, opportunities, and useful insights
The epileptic seizures treatment market report provides current and future revenues (US$ Mn) for each of the segments for the period from 2018 to 2030, considering 2019 as the base year. The compound annual growth rate (percentage CAGR) has been provided for each segment and market from 2020 to 2030, along with market size estimations.
Regional Overview: Epileptic Seizures Treatment Market
In terms of region, the global epileptic seizures treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
North America dominated the global epileptic seizures treatment market in 2019, and the trend is projected to continue during the forecast period
The current and future sizes of the epileptic seizures treatment market, in terms of value (US$ Mn), of regional markets and their major countries have been provided in the report for the period from 2018 to 2030, along with their CAGRs for the period from 2020 to 2030
The study also offers a list of recommendations, highlights, and useful insights of the market, which would help new companies willing to enter the market and existing companies to increase market shares and help in the decision-making process
Major Players
The epileptic seizures treatment market report concludes with the company profiles section that includes key information about the major players in the market
Key players analyzed in the epileptic seizures treatment market report are
- Bausch Health Companies, Inc.
- GlaxoSmithKline plc.
- UCB S.A.
- Pfizer, Inc.
- Apotex, Inc.
- Alexza Pharmaceuticals, Inc.
- Neurelis, Inc.
- Veriton Pharma
Each of these players has been profiled in the global epileptic seizures treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments
Key Questions Answered in Epileptic Seizures Treatment Market Report
- What is the sales/revenue generated by each therapeutic, type, route of administration, and distribution channel segment of the global epileptic seizures treatment market across all regions during the forecast period?
- What are the opportunities in the global epileptic seizures treatment market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which region is likely to expand at the fastest CAGR during the forecast period?
- Which epileptic seizures treatment segments are expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
- What is the market share or position of different companies operating in the global market in 2019?
Epileptic Seizures Treatment Market – Segmentation
Therapeutic
- Midazolam
- Alprazolam
- Diazepam
- Lorazepam
- Phenytoin
- Fosphenytoin
- Others
Type
- Repetitive Seizures
- Status Epilepticus
- Convulsive Status Epilepticus
- Non-convulsive Status Epilepticus
- Others
Route of Administration
- Oral/Buccal
- Rectal
- Nasal
- Parenteral
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/111591/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/